Skip to main content
. 2022 Jun 30;144(2):339–352. doi: 10.1007/s00401-022-02460-1

Fig. 4.

Fig. 4

Progression-free (a) and overall (b) survival for Grp 3 MB combining various HIT regimens (RT/CHT vs. CHT alone) and KIRREL2 expression levels. High KIRREL2 was associated with adverse outcomes for patients treated either with CHT alone or combined RT/CHT as compared to those with low levels of KIRREL2